Poly(L-glutamic acid) Microsphere: Preparation and Application in Oral Drug Controlled Release

doi:10.6023/A14110767

Acta Chimica Sinica ›› 2015, Vol. 73 ›› Issue (1): 60-65.DOI: 10.6023/A14110767 Previous Articles

Article

聚(L-谷氨酸)微球的制备及其口服药物控释研究

赵丽^b, 丁建勋^a, 肖春生^a, 陈学思^a, 盖广清^b, 王立艳^c

a 中国科学院长春应用化学研究所中国科学院生态环境高分子材料重点实验室长春 130022;
b 吉林建筑大学建筑节能技术工程实验室长春 130118;
c 吉林建筑大学材料科学与工程学院长春 130118

投稿日期:2014-11-09 发布日期:2015-01-06
通讯作者: 肖春生 E-mail:xiaocs@ciac.ac.cn
基金资助:
项目受国家自然科学基金(Nos. 51403075, 51303174, 51203153, 51390484, 51233004, 51321062)及吉林省科技发展计划基金(No. 20140520050JH)资助.

Poly(L-glutamic acid) Microsphere: Preparation and Application in Oral Drug Controlled Release

Zhao Li^b, Ding Jianxun^a, Xiao Chunsheng^a, Chen Xuesi^a, Gai Guangqing^b, Wang Liyan^c

a Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022;
b Laboratory of Building Energy-Saving Technology Engineering, Jilin Jianzhu University, Changchun 130118;
c College of Material Science and Engineering, Jilin Jianzhu University, Changchun 130118

Received:2014-11-09 Published:2015-01-06
Supported by:
Project supported by the National Natural Science Foundation of China (Nos. 51403075, 51303174, 51203153, 51390484, 51233004, 51321062) and the Scientific Development Program of Jilin Province (No. 20140520050JH).

Poly(L-glutamic acid) (PLG) and its derivatives, which are biodegradable and biocompatible, are one kind of the most widely investigated synthetic polypeptides as biomedical materials benefited from their pH-responsive property (pK_a～4.1) and modifiable side carboxyl group. In this work, PLG was synthesized via a two-step procedure. Poly(γ-benzyl-L-glutamate) (PBLG) was first synthesized by the ring-opening polymerization of γ-benzyl-L-glutamate-N-carboxyanhydride (BLG-NCA) using n-hexylamine as initiator, and then PLG was prepared by the deprotection of benzyl groups in PBLG. PLG microsphere was prepared by the oil-in-oil (O/O) anhydrous emulsion method utilizing N,N-dimetylformamide as an inner oil phase and corn oil as an outer oil phase. Rifampicin, a model drug, was loaded into the PLG microsphere, and the drug loading capacity and entrapment efficiency were revealed. The scanning electron microscopy micrograph indicated that the drug-loaded microsphere exhibited spherical morphology with narrow size distribution and average diameter at about 9.0 μm. To investigate the application of PLG microsphere in oral drug delivery (especially for enteric-coated drugs), the in vitro rifampicin release experiments in simulated gastric or intestinal fluid were performed. In vitro release results revealed that the release of rifampicin from microsphere was highly dependent on pH. In detail, less amount of rifampicin was released in simulated gastric fluid, while the quicker release of rifampicin occurred in simulated intestinal fluid. It was because that the deprotonation of carboxyl groups in PLG caused the loose, expansion, and even disintegration of PLG microsphere in simulated intestinal fluid. Moreover, the morphology of microsphere in simulated gastric fluid was different from that in simulated intestinal fluid, which further confirmed the pH-sensitive property of microsphere. Additionally, in vitro methyl thiazolyl tetrazolium assays demonstrated that the PLG microsphere was biocompatible. Therefore, the biocompatible PLG microsphere with the intelligent pH-triggered drug release should be promising for application in oral drug delivery.

Key words: enteric carrier, poly(L-glutamic acid), oral administration, microsphere, drug delivery

Cite this article

Zhao Li, Ding Jianxun, Xiao Chunsheng, Chen Xuesi, Gai Guangqing, Wang Liyan. Poly(L-glutamic acid) Microsphere: Preparation and Application in Oral Drug Controlled Release[J]. Acta Chimica Sinica, 2015, 73(1): 60-65.

Export EndNote|Reference Manager|ProCite|BibTeX|RefWorks

share this article

References

[1] Alessandra, M.; Lucia, Z.; Maria, D. D. C.; Anastasia, F.; Andrea, G. Adv. Drug Delivery Rev. 2012, 64, 540.
[2] Lee, W. A.; Narog, B. A.; Patapoff, T. W.; Wang, Y. J. J. Pharm. Sci. 1991, 80,725.
[3] Brain, J. D. Diabetes Technol. Ther. 2007, 9, S4.
[4] Alabraba, V.; Farnsworth, A.; Leigh, R.; Dodson, P.; Gough, S. C. L.; Smyth, T. Diabetes Technol. Ther. 2009, 11, 427.
[5] Chen, H.; Zhu, H.; Zheng, J.; Mou. D.; Wan, J.; Zhang, J.; Shi, T.; Zhao, Y.; Xu, H.; Yang, X. J. Controlled Release 2009, 139, 63.
[6] Thomas, B. J.; Finnin, B. C. Drug Discovery Today 2004, 9, 697.
[7] Molokhia, S. A.; Thomas, S. C.; Garff, K. J.; Mandell, K. J.; Wirostko, B. M. J. Ocul. Pharmacol. Th. 2013, 29, 92.
[8] Wang, D.; Xuan, H. X.; Lin, Q. S. Pharm. Biotechnol. 2000, 7, 57. (王瓞, 宣海星, 林其谁, 药物生物技术, 2000, 7, 57.)
[9] Iyer, H.; Khedkar, A.; Verma, M. Diabetes Obes. Metab. 2010, 12, 179.
[10] Mukhopadhyay, P.; Mishra, R.; Rana, D.; Kundu, P. P. Prog. Polym. Sci. 2012, 37, 1457.
[11] Yang, W. H.; Yu, S. Y.; Chen, S.; Liu, Y. Z.; Shao, Z. Z; Chen, X. Acta Chim. Sinica 2014, 72, 1164. (杨文华, 俞淑英, 陈胜, 刘也卓, 邵正中, 陈新, 化学学报, 2014, 72, 1164.)
[12] Jia, X. K.; Yin, J. J.; He, D. G.; He, X. X.; Wang, K. M.; Chen, M.; Li, Y. H. J. Biomed. Nanotechnol. 2013, 9, 2063.
[13] Osada, K.; Christie, R. J.; Kataoka, K. J. R. Soc. Interface 2009, 6, S325.
[14] Deming, T. J. Adv. Drug Delivery Rev. 2002, 54, 1145.
[15] Ding, J. X.; Xiao, C. S.; Tang, Z. H.; Zhuang, X. L.; Chen, X. S. Macromol. Biosci. 2011, 11, 192.
[16] Couffin-Hoarau, A. C.; Boustta, M.; Vert, M. J. Polym. Sci., Part A: Polym. Chem. 2001, 39, 3475.
[17] Kohn, J.; Langer, R. J. Am. Chem. Soc. 1987, 109, 817.
[18] Xu, X.; Wu, G. L.; Zhang, J.; Wang, Y. N.; Fan, Y. H.; Ma, J. B. Acta Chim. Sinica 2008, 66, 1102. (徐旭, 伍国琳, 张洁, 王亦农, 范云鸽, 马建标, 化学学报, 2008, 66, 1102.)
[19] Chen, L., Tian, H. Y.; Chen. J.; Chen, X. S.; Huang, Y. B.; Jing, X. B. J. Gene Med. 2010, 12, 64.
[20] Li, C. Adv. Drug Delivery Rev. 2002, 54, 695.
[21] Zhao, L.; Ding, J. X.; Xiao, C. S.; He, P.; Tang, Z. H.; Pang, X.; Zhuang, X. L.; Chen, X. S. J. Mater. Chem. 2012, 22, 12319.
[22] He, N.; Sun, H. C.; Xu, H. X.; Shao, Z. Z. Chem. J. Chin. Univ. 2014, 35, 2019. (何宁, 孙贺春, 徐欢喜, 邵张章, 高等学校化学学报, 2014, 35, 2019.)
[23] Zhang, Z.; Chen, L.; Deng, M. X.; Bai, Y. Y.; Chen, X. S.; Jing, X. B. J. Polym. Sci., Part A: Polym. Chem. 2011, 49, 2941.
[24] Han, J. D.; Ding, J. X.; Wang, Z. C.; Yan, S. F.; Zhuang, X. L.; Chen, X. S.; Yin, J. B. Sci. China, Chem. 2013, 56, 729.
[25] Leach, W. T.; Simpson, D. T.; Val, T. N.; Anuta, E. C.; Yu, Z. S.; Williams, R. O.; Johnston, K. P. J. Pharm. Sci. 2005, 94, 56.
[26] Sah, H. K. J. Pharm. Sci. 1997, 86, 1315.

聚(L-谷氨酸)微球的制备及其口服药物控释研究

Poly(L-glutamic acid) Microsphere: Preparation and Application in Oral Drug Controlled Release

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhiliang Gao, Mengqi Li, Jingcheng Hao, Jiwei Cui. Tuning the Mechanical Properties of Colloid Particles for Drug Delivery [J]. Acta Chimica Sinica, 2022, 80(7): 1010-1020.
[2]	Ruomei Liu, Yanhui Feng, Zhuo Li, Shan Lu, Tianyong Guan, Xingjun Li, Yan Liu, Zhuo Chen, Xueyuan Chen. A Novel Near-infrared Responsive Lanthanide Upconversion Nanoplatform for Drug Delivery Based on Photocleavage of Cypate^※ [J]. Acta Chimica Sinica, 2022, 80(4): 423-427.
[3]	Zheng Cai, Yingwen Zhang, Liping Jiang, Junjie Zhu. The Construction and Application of Mn₃O₄/DOX@Lip Nano-drug Delivery System Based on Fenton-Like Reaction [J]. Acta Chimica Sinica, 2021, 79(4): 481-489.
[4]	Hua Yue, Guanghui Ma. Advances in Functionalized Carriers Based on Graphene's Unique Biological Interface Effect [J]. Acta Chimica Sinica, 2021, 79(10): 1244-1256.
[5]	Zhang Liuwei, Chen Qixian, Wang Jingyun. Advances in Reactive Oxygen Species Responsive Anti-cancer Prodrugs [J]. Acta Chimica Sinica, 2020, 78(7): 642-656.
[6]	Qi Ye, Ren Shuangsong, Che Ying, Ye Junwei, Ning Guiling. Research Progress of Metal-Organic Frameworks Based Antibacterial Materials [J]. Acta Chimica Sinica, 2020, 78(7): 613-624.
[7]	Zeng Jinyue, Wang Xiaoshuang, Zhang Xianzheng, Zhuo Renxi. Research Progress in Functional Metal-Organic Frameworks for Tumor Therapy [J]. Acta Chimica Sinica, 2019, 77(11): 1156-1163.
[8]	Luo Jianxin, Yan Wenhai, Ma Qing, Zhang Chunyan, Fang Yiquan, Zhang Xucheng, Wang Changchun. Study on High Activity Monodispersed Sulfonated Porous Polystyrene Microspheres for Preparation of Biodiesel [J]. Acta Chimica Sinica, 2019, 77(1): 54-59.
[9]	Zhang Bei, Chang Baisong, Sun Taolei. Synthesis and Study of Hypoxia-Responsive Micelles Based on Hyaluronic Acid [J]. Acta Chim. Sinica, 2018, 76(1): 35-42.
[10]	Zhang Liuwei, Qian Ming, Wang Jingyun. Progress in Research of Photo-controlled Drug Delivery Systems [J]. Acta Chim. Sinica, 2017, 75(8): 770-782.
[11]	Peng Kaimei, Ding Wei, Tu Weiping, Hu Jianqing, Liu Chao, Yang Jian. Construction of Guanidinium-rich Polymers and Their Applications [J]. Acta Chim. Sinica, 2016, 74(9): 713-725.
[12]	Zhang Shaofei, Yang Jiandong, Liu Mingzhu, Lü Shaoyu, Gao Chunmei, Wu Can, Zhu Zhaoyan. Synthesis of Peptide Dendrimers and Their Application in the Drug Delivery System [J]. Acta Chim. Sinica, 2016, 74(5): 401-409.
[13]	Wang Xin, Tan Lili, Yang Yingwei. Controlled Drug Release Systems Based on Mesoporous Silica Capped by Gold Nanoparticles [J]. Acta Chim. Sinica, 2016, 74(4): 303-311.
[14]	Wu Keyi, Guo Jia. Controllable Synthesis of Multi-Scale Conjugated Microporous Polymer [J]. Acta Chim. Sinica, 2015, 73(6): 480-486.
[15]	Lian Youfen, Yan Lulu, Wang Yu, Qi Xinhua . One-step Preparation of Carbonaceous Solid Acid Catalysts by Hydrothermal Carbonization of Fructose for Cellulose Hydrolysis [J]. Acta Chimica Sinica, 2014, 72(4): 502-507.